TGen licenses first drug for patient use in clinical care
The Translational Genomics Research Institute (TGen) has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins.
View ArticleSafety concerns about adulterated drug ingredients
Government regulators and pharmaceutical companies are moving to address a major new risk for the global supply of medicines: The possibility that unsafe ingredients are entering the supply chain as...
View ArticleStudy reveals that financial conflicts of interest are associated with...
Results demonstrate that 91% of RCTs recording this kind of FCOI achieved a positive - outcome, compared to 66.7% of RCTs without specific FCOI (p=0.02) and adjusting for confounding factors did not...
View ArticleNew development could increase flu vaccine supply
(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed...
View ArticlePurdue takes prostate cancer treatment from concept to clinical trial
(Medical Xpress) -- A clinical trial for a new technology to diagnose and treat prostate cancer marks the first time Purdue University has directed the entire pathway of a therapeutic product from...
View ArticleSafe prescribing information for children in Canada often hard to find
Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in...
View ArticleNew treatments for mental illness under threat
(Medical Xpress) -- Scientists have voiced their serious concerns over major pharmaceutical companies abrupt withdrawal from research into mental illness and neurological diseases.
View ArticleClinical study of epilepsy drug may have been purely promotional
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase...
View ArticleNew understanding of biomarkers could lead to earlier diagnosis of fatal...
A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' - proteins which reveal information about the condition of the human body. This new...
View ArticleAIDS conference opens in Rome
(AP) -- The head of the United Nations AIDS program called Sunday for an increase in access to drugs that help treat or prevent the spread of the disease, saying it is "morally wrong" to keep millions...
View ArticleUS pharmacy giant buys rival for $29.1 billion
Pharmacy benefits manager Express Scripts said Thursday it had reached a deal to buy its competitor Medco Health Systems for $29.1 billion, ahead of looming changes in the US healthcare system.
View ArticleFaulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault...
View ArticlePublic disclosure of clinical trial results by Health Canada should be mandatory
Health Canada is not prevented by law from publicly disclosing safety and efficacy data from clinical trials, pharmaceuticals, biologics and medical devices and should be more transparent, states an...
View ArticleFear in US as drug shortages mount
Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.
View ArticleScientists uncover new ways to stimulate pancreatic beta cell growth
One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find drugs that target these molecules. Now, JDRF-funded researchers in collaboration with...
View ArticleSubstitution of brand name with generic drug proves safe for transplant...
A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of...
View ArticleDivide over when to use in-depth cholesterol tests
For heart health, you're supposed to know your numbers: Total cholesterol, the bad LDL kind and the good HDL kind. But your next checkup might add a new number to the mix.
View ArticleProfessor helps develop promising Ebola drug
As the Ebola crisis in Africa continues and concern ramps up in the United States, a pharmaceutical company with a Corvallis connection is ready to respond with a limited amount of a potentially...
View ArticleStudy examines FDA influence on design of pivotal drug studies
An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug...
View ArticleNew substance overcomes treatment-restistance in leukemia
Haematologists from Goethe University Frankfurt, working with a Russian pharmaceutical company, have developed a new active substance that effectively combats the most aggressive forms of Philadelphia...
View Article
More Pages to Explore .....